newsfilter
← Latest News
PR Newswire·

MiniMed to Showcase MiniMed Flex™ and MiniMed Go™ at the American Diabetes Association Scientific Sessions

  • MiniMed will present at the American Diabetes Association's Scientific Sessions in New Orleans from June 5-8, 2026, marking its first U.S. diabetes congress since becoming a standalone public company.
  • The company will showcase hands-on demonstrations of the newly launched MiniMed Go™ smart insulin pen system & the upcoming MiniMed Flex™ screenless pump with SmartGuard™ automation.
  • MiniMed will present emerging clinical data regarding its refreshed sensor portfolio & the real-world impact of its connected solutions.
  • Scheduled sponsored events include a Product Theater on June 6 discussing new insulin delivery systems, a Learning Byte on June 7 by CMO Robert Vigersky, & an exhibit at Booth #1406 featuring interactive components.
  • Scientific presentations will include 14 poster sessions covering topics such as automated insulin delivery in Puerto Rico, 3-year glycemic sustainability in Latin America, language setting comparisons, & pediatric outcomes.
  • Research highlights include data on Medicaid & Medicare beneficiaries achieving ADA-recommended targets, performance of the 15-day Instinct™ Sensor vs. the 7-day Simplera Sync™ Sensor, & firmware update safety.
  • MiniMed operates as a global leader in insulin delivery across 80 countries with a mission to reduce diabetes burden through its integrated ecosystem of pumps, CGMs, algorithms, & apps.